Clinical trial
Satisfaction, Adherence, Effectiveness, and Safety of Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Treatment in Patients With Acne Vulgaris: A Canadian Prospective Phase IV Study (CHARM)
NCT07205107 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Satisfaction, Adherence, Effectiveness, and Safety of Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Treatment in Patients With Acne Vulgaris: A Canadian Prospective Phase IV Study (CHARM)
- Lead sponsor
- Bausch Health Americas, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 2, 2025
- Completion date
- August 3, 2026
- Enrollment
- 200 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.